Contact Us

N6-Methyladenosine-5'-Triphosphate - (N-1013)

N6-Methyl-ATP, m6ATP
In stock
Product SKU Unit Size Price Qty
N-1013-1 1 µmole
N-1013-5 5 µmole
N-1013-10 10 µmole
N6-methyl adenosine (N6-methyl ATP) is a base modified analog of adenosine and is found as a minor nucleoside in natural RNAs (Meyer et al.). N6-methyl ATP can substitute for ATP in some biological systems, and is a potent agonist for P2Y-purinoceptors in the guinea pig, taenia coli (Burnstock et al.). In vitro studies showed that N6-methyl ATP substituted for ATP and supported cytoskeletal filament-driven translocation of motor proteins (dynein, kinesin and myosin) (Schliwa et al. & Shimizu et al.). N6-methyl ATP is also a substrate for RNA polymerase and can be used for preparation of modified RNA (Rohayem & Kariko et al.).
Product details
Catalog No N-1013
Purity ≥90% by AX-HPLC
Extinction Coefficient 15,567 Lmol-1cm-1 at 265 nm
Molecular Formula C11H18N5O13P3 (free acid)
Molecular Weight 521.20 g/mole (free acid)
Salt Form Li+
Concentration 100 mM
Buffer H2O
Recommended Storage -20°C or below
Other Name(s) N6-Methyl-ATP, m6ATP
Application Aptamers, Epigenetics/DNA Damage, In vitro Transcription, Mutagenesis, Photocrosslinking Studies
Backbone 5'-Triphosphate
Base Analog(s) Adenosine
Sugar Type(s) RNA
Nucleotide Category Base Modified RNA
Technical documents

N-1013 Safety Data Sheet

Products faqs

Ask an Expert

Certificate of analysis

CoA search tool

Intellectual property

Products are for research use only, not for use in diagnostic or therapeutic procedures or for use in humans. Products are not for resale without express written permission from TriLink No license under any patent or other intellectual property right of TriLink or its licensors is granted or implied by the purchase unless otherwise provided in writing.

TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser's sole responsibility.

  1. Missiaen, L.; Parys, J. B.; Smedt, H. D.; Sienaert, I.; Sipma, H.; Vanlingen, S.; Maes, K.; Casteels, R. . Effect of adenine nucleotides on myo-inositol-1,4,5-trisphosphate-induced calcium release.
  2. Karikó, Katalin; Muramatsu, Hiromi; Welsh, Frank A.; Ludwig, János; Kato, Hiroki; Akira, Shizuo; Weissman, Drew . Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
  3. Karikó, Katalin; Buckstein, Michael; Ni, Houping; Weissman, Drew . Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.
  4. Anderson, Bart R.; Muramatsu, Hiromi; Nallagatla, Subba R.; Bevilacqua, Philip C.; Sansing, Lauren H.; Weissman, Drew; Karikó, Katalin . Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.
  5. Anderson, Bart R.; Muramatsu, Hiromi; Jha, Babal K.; Silverman, Robert H.; Weissman, Drew; Karikó, Katalin . Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L.
  6. Motorin, Yuri; Helm, Mark . RNA nucleotide methylation.
  7. Alarcón, Claudio R.; Lee, Hyeseung; Goodarzi, Hani; Halberg, Nils; Tavazoie, Sohail F. . N6-methyladenosine marks primary microRNAs for processing.
  8. Durbin, Ann Fiegen; Wang, Chen; Marcotrigiano, Joseph; Gehrke, Lee . RNAs Containing Modified Nucleotides Fail To Trigger RIG-I Conformational Changes for Innate Immune Signaling.
  9. Wang, Haiyan; Qi, Chunling; He, Wenhuan; Wang, Minghui; Jiang, Wenjing; Yin, Huanshun; Ai, Shiyun . A sensitive photoelectrochemical immunoassay of N(6)-methyladenosine based on dual-signal amplification strategy: Ru doped in SiO(2) nanosphere and carboxylated g-C(3)N(4).
  10. Potapov, Vladimir; Fu, Xiaoqing; Dai, Nan; Corrêa, Ivan R. Jr; Tanner, Nathan A.; Ong, Jennifer L. . Base modifications affecting RNA polymerase and reverse transcriptase fidelity.
  11. Lee, JH;Wang, R;Xiong, F;Krakowiak, J;Liao, Z;Nguyen, PT;Moroz-Omori, EV;Shao, J;Zhu, X;Bolt, MJ;Wu, H;Singh, PK;Bi, M;Shi, CJ;Jamal, N;Li, G;Mistry, R;Jung, SY;Tsai, KL;Ferreon, JC;Stossi, F;Caflisch, A;Liu, Z;Mancini, MA;Li, W; . Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation
  12. Chen, YG;Chen, R;Ahmad, S;Verma, R;Kasturi, SP;Amaya, L;Broughton, JP;Kim, J;Cadena, C;Pulendran, B;Hur, S;Chang, HY; . N6-Methyladenosine Modification Controls Circular RNA Immunity
  13. Liu, H;Begik, O;Lucas, MC;Ramirez, JM;Mason, CE;Wiener, D;Schwartz, S;Mattick, JS;Smith, MA;Novoa, EM; . Accurate detection of m6A RNA modifications in native RNA sequences
  14. Zhang, X;Wang, Y;Zhou, X; . A Ligation-Based qPCR Amplification Assay for the Radiolabeling-Free Detection of ATP/NAD+ with High Selectivity and Sensitivity
  15. Kim, K;van Galen, P;Hovestadt, V;Rahme, G;Andreishcheva, E;Shinde, A;Gaskell, E;Jones, D;Shema, E;Bernstein, B; . Systematic detection of m6A-modified transcripts at single-molecule and single-cell resolution
  16. Kontur, C; . RNA Methylation and Ythdf Readers in Posttranscriptional Regulation and Development
  17. Valentini, P;Pierattini, B;Zacco, E;Mangoni, D;Espinoza, S;Webster, N;Andrews, B;Carninci, P;Tartaglia, G;Pandolfini, L;Gustincich, S; . Towards SINEUP-based therapeutics: design of an in vitro synthesized SINEUP RNA
  18. Aditham, A;Shi, H;Guo, J;Zeng, H;Zhou, Y;Wade, SD;Huang, J;Liu, J;Wang, X; . Chemically Modified mocRNAs for Highly Efficient Protein Expression in Mammalian Cells
Show more